RTG 300 (Potiga 300 mg)
Generic Name: ezogabine
Pill imprint RTG 300 has been identified as Potiga 300 mg.
Potiga is used in the treatment of epilepsy; seizures and belongs to the drug class neuronal potassium channel openers. Risk cannot be ruled out during pregnancy. Potiga 300 mg has a low potential for abuse relative to the drugs in schedule 4. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.
See also related documents.
Images for RTG 300 (Potiga 300 mg)
- Generic Name:
- ezogabine
- Imprint:
-
RTG 300
- Strength:
- 300 mg
- Color:
- Green
- Shape:
- Rectangle
- Availability:
- Prescription only
- Drug Class:
- Neuronal potassium channel openers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Manufacturer:
- GlaxoSmithKline
- National Drug Code (NDC):
- 00173-0813
More resources
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

